Astellas CEO Yasukawa On Enabling Faster R&D
TPDs One Beneficiary
Keeping the company focus on launching innovating drugs, Astellas CEO Kenji Yasukawa talks in part one of this exclusive interview on how the Japanese firm transformed its R&D processes to allow more flexible and agile decision-making beyond the wall of multiple sections.
